News + Filings Transactions
|
GUGGENHIME ANDREW
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/21/2023 | Caribou Biosciences, Inc. | CRBU | Grant | Option to purchase Common Stock | 21.5k | $6.12 | $131.6k | | 02/21/2023 |
| 12/30/2022 | Vaxcyte, Inc. | PCVX | Grant | Stock Option (right to buy) | 42k | $47.95 | $2M | | 12/30/2022 |
| 12/30/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 23.7k | $5.35 | $126.7k | | 12/30/2022 |
| 09/19/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 09/19/2022 |
| 09/19/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 477 | $26.52 | $12.7k | | 09/19/2022 |
| 09/19/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 2.6k | $26.02 | $68.2k | | 09/19/2022 |
| 09/02/2022 | Vaxcyte, Inc. | PCVX | Payment of Exercise | Common Stock | 4.6k | $26.38 | $122.6k | | 09/02/2022 |
| 08/29/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 17.7k | $5.35 | $94.4k | | 08/25/2022 |
| 08/29/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 17.7k | $28.00 | $494.3k | | 08/25/2022 |
| 08/26/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 1.3k | $5.35 | $6.9k | | 08/25/2022 |
| 08/26/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 1.3k | $28.00 | $36.3k | | 08/25/2022 |
| 08/25/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 17.1k | $28.00 | $477.5k | | 08/25/2022 |
| 08/25/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 17.1k | $5.35 | $91.2k | | 08/25/2022 |
| 08/18/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 08/18/2022 |
| 08/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 2.6k | $25.13 | $64.1k | | 08/18/2022 |
| 08/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 549 | $25.89 | $14.2k | | 08/18/2022 |
| 07/18/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 07/18/2022 |
| 07/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 9 | $25.00 | $225 | | 07/18/2022 |
| 07/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 3.1k | $24.53 | $75.8k | | 07/18/2022 |
| 07/08/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 3.1k | $24.00 | $74.4k | | 07/08/2022 |
| 07/08/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 07/08/2022 |
| 05/18/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 05/18/2022 |
| 05/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 2.5k | $24.26 | $61.1k | | 05/18/2022 |
| 05/18/2022 | Metacrine, Inc. | MTCR | Grant | Stock Option (right to buy) | 16.5k | $0.42 | $6.9k | | 05/18/2022 |
| 05/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 580 | $25.22 | $14.6k | | 05/18/2022 |
| 04/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 3.1k | $24.05 | $74.5k | | 04/18/2022 |
| 04/18/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 04/18/2022 |
| 03/18/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 3.1k | $26.13 | $81k | | 03/18/2022 |
| 03/18/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 03/18/2022 |
| 03/02/2022 | Vaxcyte, Inc. | PCVX | Grant | Stock Option (right to buy) | 225k | $24.79 | $5.6M | | 03/02/2022 |
| 03/02/2022 | Vaxcyte, Inc. | PCVX | Grant | Common Stock | 37.5k | $0.00 | $0 | | 03/02/2022 |
| 03/01/2022 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 6.2k | $24.00 | $148.8k | | 03/01/2022 |
| 03/01/2022 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 6.2k | $5.35 | $33.2k | | 03/01/2022 |
| 12/23/2021 | Vaxcyte, Inc. | PCVX | Exercise | Stock Option (right to buy) | 3.1k | $5.35 | $16.6k | | 12/23/2021 |
| 12/23/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 3.1k | $24.00 | $74.4k | | 12/23/2021 |
|
|